Microbio’s bloodstream infection test cleared for sale in Europe

14 June 2022

 

Australian biotech scaleup, Microbio is set to break into the European market with its flagship bloodstream infection (BSI) test. Following extensive clinical evaluation trials, the company has been granted a CE Mark, which has opened the door for distribution and use in Europe.

Read more in the media release: 220614_Australian_bloodstream_infection_test_cleared_for_sale_in_Europe